Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francesco Angelucci

Showing results (51-60 of 166) with videos related to

Pageof 17
Sort By:
The International Journal of Neuropsychopharmacology|May 10, 2001
Chronic antipsychotic treatment selectively alters nerve growth factor and neuropeptide Y immunoreactivity and the distribution of choline acetyl transferase in rat brain regionsFrancesco Angelucci, Luigi Aloe, Susanne H. M. Gruber, et al.
Journal of Psychopharmacology (Oxford, England)|April 5, 2014
Effects of lithium and valproic acid on BDNF protein and gene expression in an in vitro human neuron-like model of degenerationNicoletta Croce, Aleksander A Mathé, Francesca Gelfo, et al.
Proteins|February 27, 2008
Glutathione reductase and thioredoxin reductase at the crossroad: the structure of Schistosoma mansoni thioredoxin glutathione reductaseFrancesco Angelucci, Adriana E Miele, Giovanna Boumis, et al.
Protein Science : a Publication of the Protein Society|April 6, 2011
Structural and functional characterization of Schistosoma mansoni ThioredoxinGiovanna Boumis, Francesco Angelucci, Andrea Bellelli, et al.
The Journal of ECT|January 6, 2011
Brain-derived neurotrophic factor and electroconvulsive therapy in a schizophrenic patient with treatment-resistant paranoid-hallucinatory symptomsGiovanni Martinotti, Valerio Ricci, Marco Di Nicola, et al.
Psychopharmacology|December 17, 2010
Chronic ketamine use increases serum levels of brain-derived neurotrophic factorValerio Ricci, Giovanni Martinotti, Francesca Gelfo, et al.
FEBS Open Bio|June 18, 2013
Nitric oxide, substrate of Euphorbia characias peroxidase, switches off the CN(-) inhibitory effectFrancesca Pintus, Delia Spanò, Andrea Bellelli, et al.
Epilepsy & Behavior : E&B|January 23, 2026
Emotion recognition deficits in temporal lobe epilepsy are non-lateralized and independent of surgeryJana Amlerova, Viktoria Pytelova, Francesco Angelucci, et al.
Neuro-Degenerative Diseases|February 25, 2011
Neuroprotective effect of neuropeptide Y against β-amyloid 25-35 toxicity in SH-SY5Y neuroblastoma cells is associated with increased neurotrophin productionNicoletta Croce, Vincenzo Dinallo, Valerio Ricci, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|September 9, 2008
Reduced serum concentrations of nerve growth factor, but not brain-derived neurotrophic factor, in chronic cannabis abusersFrancesco Angelucci, Valerio Ricci, Gianfranco Spalletta, et al.
Pageof 17

Showing results (51-60 of 166) with videos related to

Sort By:
Pageof 17
The International Journal of Neuropsychopharmacology|May 10, 2001
Chronic antipsychotic treatment selectively alters nerve growth factor and neuropeptide Y immunoreactivity and the distribution of choline acetyl transferase in rat brain regionsFrancesco Angelucci, Luigi Aloe, Susanne H. M. Gruber, et al.
Journal of Psychopharmacology (Oxford, England)|April 5, 2014
Effects of lithium and valproic acid on BDNF protein and gene expression in an in vitro human neuron-like model of degenerationNicoletta Croce, Aleksander A Mathé, Francesca Gelfo, et al.
Proteins|February 27, 2008
Glutathione reductase and thioredoxin reductase at the crossroad: the structure of Schistosoma mansoni thioredoxin glutathione reductaseFrancesco Angelucci, Adriana E Miele, Giovanna Boumis, et al.
Protein Science : a Publication of the Protein Society|April 6, 2011
Structural and functional characterization of Schistosoma mansoni ThioredoxinGiovanna Boumis, Francesco Angelucci, Andrea Bellelli, et al.
The Journal of ECT|January 6, 2011
Brain-derived neurotrophic factor and electroconvulsive therapy in a schizophrenic patient with treatment-resistant paranoid-hallucinatory symptomsGiovanni Martinotti, Valerio Ricci, Marco Di Nicola, et al.
Psychopharmacology|December 17, 2010
Chronic ketamine use increases serum levels of brain-derived neurotrophic factorValerio Ricci, Giovanni Martinotti, Francesca Gelfo, et al.
FEBS Open Bio|June 18, 2013
Nitric oxide, substrate of Euphorbia characias peroxidase, switches off the CN(-) inhibitory effectFrancesca Pintus, Delia Spanò, Andrea Bellelli, et al.
Epilepsy & Behavior : E&B|January 23, 2026
Emotion recognition deficits in temporal lobe epilepsy are non-lateralized and independent of surgeryJana Amlerova, Viktoria Pytelova, Francesco Angelucci, et al.
Neuro-Degenerative Diseases|February 25, 2011
Neuroprotective effect of neuropeptide Y against β-amyloid 25-35 toxicity in SH-SY5Y neuroblastoma cells is associated with increased neurotrophin productionNicoletta Croce, Vincenzo Dinallo, Valerio Ricci, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|September 9, 2008
Reduced serum concentrations of nerve growth factor, but not brain-derived neurotrophic factor, in chronic cannabis abusersFrancesco Angelucci, Valerio Ricci, Gianfranco Spalletta, et al.
Pageof 17